Flow cytometric analysis of circulating dendritic cell subsets and intracellular cytokine production in advanced breast cancer patients

Oncology Reports

Volumn 14, Issue 1, 2005, Pages 113-120

  Ferrari, Silvia ^a   Malugani, Fabio ^a   Rovati, Bianca ^a   Porta, Camillo ^a   Riccardi, Alberto ^a   Danova, Marco ^a  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

Breast cancer; Cytokines; Dendritic cells; Flow cytometry

Indexed keywords

ANTINEOPLASTIC AGENT; CD123 ANTIGEN; CYTOKINE; GAMMA INTERFERON; GLYCOPROTEIN P 15095; HLA DR ANTIGEN; IL3RA PROTEIN, HUMAN; INTERLEUKIN 3 RECEPTOR; INTERLEUKIN 4; PHORBOL 13 ACETATE 12 MYRISTATE;

ADULT; AGED; ARTICLE; BLOOD; BREAST TUMOR; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL LINEAGE; COMPARATIVE STUDY; CYTOLOGY; DENDRITIC CELL; DRUG EFFECT; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOLOGY; INTRACELLULAR SPACE; METABOLISM; METHODOLOGY; MIDDLE AGED; TIME; TREATMENT OUTCOME;

ADULT; AGED; ANTIGENS, CD11C; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL LINEAGE; CYTOKINES; DENDRITIC CELLS; FEMALE; FLOW CYTOMETRY; HLA-DR ANTIGENS; HUMANS; INTERFERON TYPE II; INTERLEUKIN-3 RECEPTOR ALPHA SUBUNIT; INTERLEUKIN-4; INTRACELLULAR SPACE; MIDDLE AGED; RECEPTORS, INTERLEUKIN-3; TETRADECANOYLPHORBOL ACETATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 24644461251     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Almand B, Resser JR, Lindman B, Nadaf S, Clark JI, Kwon ED, Carbone DP and Gabrilovich DI: Clinical significance of defective dendritic cell differentiation in cancer. Clin Cancer Res 6: 1755-1766, 2000. (Pubitemid 30305068)
2. Sato M, Goto S, Kaneko R, Ito M, Sato S and Takeuchi S: Impaired production of Th 1 cytokines and increased frequency of Th2 subsets in PBMC from advanced cancer patients. Anticancer Res 18: 3951-3955, 1998. (Pubitemid 28561086)
3. Mackall CL: T-cell immunodeficiency following cytotoxic antineoplastic therapy: a review. Stem Cells 18: 10-18, 2000.
4. Engleman EG: Dendritic cell-based cancer immunotherapy. Semin Oncol 30 (suppl 8): 23-29, 2003.
5. Liu YJ, Kanzler H, Soumelis V and Gilliet M: Dendritic cell lineage, plasticity and cross-regulation. Nat Immunol 2: 585-589, 2001. (Pubitemid 32677624)
6. MacDonald KP, Munster DJ, Clark GJ, Dzionek A, Schimtz J and Hart DN: Characterization of human blood dendritic cell subsets. Blood 100: 4512-4520, 2002. (Pubitemid 35429692)
7. Shortman K and Liu YJ: Mouse and human dendritic cells subtypes. Nature Rev Immunol 3: 151-161, 2002. (Pubitemid 37336516)
8. Ardavin C, Martinez del Hoyo G, Martin P, Anjuere F, Arias CF, Marin AR, Ruiz S, Parrillas V and Hernandez H: Origin and differentiation of dendritic cells. Trends Immunol 22: 691-700, 2001. (Pubitemid 34008606)
9. Rissoan MC, Soumelis V, Kadowaki N, Grouard G, Briere F, de Waal Malefyt R and Liu YJ: Reciprocal control of T helper cell and dendritic cell differentiation. Science 283: 1183-1186, 1999.
10. Grouard G, Rissoan MC, Filgueira L, Durand I, Banchereau J and Liu YJ: The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand. J Exp Med 185: 1101-1111, 1997. (Pubitemid 27136802)
11. Ferrari S, Rovati B, Porta C, Alessandrino PE, Bertolini A, Collova E, Riccardi A and Danova M: Lack of dendritic cell mobilization into the peripheral blood of cancer patients following standard- or high-dose chemotherapy plus granulocytecolony stimulating factor. Cancer Immunol Immunother 52: 359-366, 2003. (Pubitemid 36693756)
12. Sander B, Andersson J and Andersson U: Assessment of cytokines by immunofluorescence and the paraformaldehydesaponin procedure. Immunol Rev 119: 65-93, 1991.
13. Jung T, Schauer U, Heusser C, Neumann C and Rieger C: Detection of intracellular cytokines by flow cytometry. J Immunol Methods 159: 197-207, 1993.
14. Rostaing L, Tkazuk J, Durand M, Deres C, Durand D, de Preval C, Ohayon E and Abbal M: Kinetics of intracytoplasmic Thl and Th2 cytokine production assessed by flow cytometry following in vitro activation of peripheral blood mononuclear cells. Cytometry 35: 318-328, 1999. (Pubitemid 29160230)
15. Banchereau J and Steinman RM: Dendritic cells and the control of immunity. Nature 392: 245-252, 1998. (Pubitemid 28155090)
16. Nestle FO, Banchereau J and Hart D: Dendritic cells: on the move from bench to bedside. Nat Med 7: 761-765, 2001. (Pubitemid 32691622)
17. Dzionek A, Fuchs A, Schmidt P, Cremer S, Zysk M, Miltenyi S, Buck DW and Schmitz J: BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood. J Immunol 165: 6037-6046, 2000.
18. Pulendran B, Smith JL, Caspary G, Brasel K, Pettit D, Maraskovsky E and Maliszewski CR: Distinct dendritic cell subsets differentially regulate the class of immune response in vivo. Proc Natl Acad Sci USA 96: 1036-1041, 1999.
19. Tanaka H, Demeure CE, Rubio M, Delespesse G and Sarfati M: Human monocyte-derived dendritic cells induce naive T cell differentiation into T helper cell type 2 (Th2) or Th1/Th2 effectors. Role of stimulator/responder ratio. J Exp Med 192: 405-412, 2000.
20. Abbas AK, Murphy KM and Sher A: Functional diversity of helper T lymphocytes. Nature 383: 787-793, 1996. (Pubitemid 26372655)
21. Assenmacher M, Schmitz J and Radbruch A: Flow cytometric determination of cytokines in activated murine T helper lymphocytes: expression of interleukin-10 in interferon-gamma and in interleukin-4-expressing cells. Eur J Immunol 24: 1097-1101, 1994. (Pubitemid 24132241)
22. Bueno C, Almeida J, Alguero MC, Sanchez ML, Vaquero JM, Laso FJ, San Miguel JF, Escribano L and Orfao A: Flow cytometric analysis of cytokine production by normal human peripheral blood dendritic cells and monocytes: comparative analysis of different stimuli, secretion-blocking agents and incubation periods. Cytometry 46: 33-40, 2001. (Pubitemid 32216736)
23. Tatsumi H, Ura H, Ikeda S, Yamaguchi K, Katsuramaki T, Asai Y and Hirata K: Surgical influence on TH1/TH2 balance and monocyte surface antigen expression and its relation to infectious complications. World J Surg 27: 522-528, 2003. (Pubitemid 36961119)
24. Ito N, Nakamura H, Tanaka Y and Ohgi S: Lung carcinoma: analysis of T helper type 1 and 2 cells and T cytotoxic type 1 and 2 cells by intracellular cytokine detection with flow cytometry. Cancer 85: 2359-2367, 1999. (Pubitemid 29244844)
25. Almand B, Clark JL Nikitina E, van Beynen J, English NR, Knight SC, Carbone DP and Gabrilovich DI: Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer. J Immunol 166: 678-689, 2001. (Pubitemid 32038493)
26. Lissoni P, Vigore L, Ferranti R, Bukovec R, Meregalli S, Mandala M, Barni S, Tancini G, Fumagalli L and Giani L: Circulating dendritic cells in early and advanced cancer patients: diminished percent in the metastatic disease. J Biol Regul Homeost Agents 13: 216-219, 1999.
27. Basak SK, Harui A, Stolina M, Sharma S, Mitani K, Dubinett SM and Roth MD: Increased dendritic cell number and function following continuous in vivo infusion of granulocyte macrophage-colony-stimulating factor and interleukin-4. Blood 99: 2869-2879, 2002. (Pubitemid 34525376)
28. Riccardi A, Pugliese P, Danova M, Brugnatelli S, Grasso D, Giordano M, Bernardo G, Giardina G, Fava S, Montanari G, Pedrotti C, Trotti G, Rinaldi E, Poli MA and Tinelli C: A phase II study of sequential 5-fluorouracil, epirubicin and cyclophosphamide (FEC) and paclitaxel in advanced breast cancer (Protocol PV BC 97/01). Br J Cancer 85: 141-146, 2001. (Pubitemid 32695731)
29. Hoffmann TK, Muller-Berghaus J, Ferris RL, Johnson JT, Storkus WJ and Whiteside TL: Alterations in the frequency of dendritic cell subsets in the peripheral circulation of patients with squamous cell carcinomas of the head and neck. Clin Cancer Res 8:1787-1793, 2002. Erratum in: Clin Cancer Res 9: 441-447, 2003 (Pubitemid 34633736)
30. Gabrilovich DI: Decreased antigen presentation by dendritic cells in patients with breast cancer. Clin Cancer Res 3: 483-490, 1997.
31. +cell-derived dendritic cells. Int J Oncol 21: 509-514, 2002.